Home  |  Contact

Cellosaurus PEO1-CDDP (CVCL_Y032)

[Text version]

Cell line name PEO1-CDDP
Synonyms PEO1CDDP; PEO1 cDDPr
Accession CVCL_Y032
Resource Identification Initiative To cite this cell line use: PEO1-CDDP (RRID:CVCL_Y032)
Comments Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
Sequence variations Hemizygous for BRCA2 p.Tyr1655Ter (5193C>G) (from parent cell line).
TP53 p.Gly244Asp (c.731G>A) (from parent cell line).
Disease BRCA2 syndrome (NCIt: C36101)
Ovarian cystadenocarcinoma (NCIt: C5228)
Hereditary breast and ovarian cancer syndrome (ORDO: Orphanet_145)
Derived from metastatic site: Ascites.
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_2686 (PEO1)
Sex of cell Female
Age at sampling Age unspecified
Category Cancer cell line
STR profile Source(s): ECACC

Markers:
AmelogeninX
CSF1PO10,12
D3S135816
D5S81811,12
D7S82010
D8S117913
D13S31710
D16S5399
D18S5116,17
D21S1132.2
FGA20
Penta D14
Penta E11,12
TH019.3
TPOX9,11
vWA15,16

Run an STR similarity search on this cell line
Publications

PubMed=8824553; DOI=10.1002/(SICI)1097-0215(19960917)67:6<816::AID-IJC10>3.0.CO;2-#
Mullen P., Ritchie A., Langdon S.P., Miller W.R.
Effect of Matrigel on the tumorigenicity of human breast and ovarian carcinoma cell lines.
Int. J. Cancer 67:816-820(1996)

Cross-references
Cell line collections ECACC; 16012001
Ximbio; 151784
Other Wikidata; Q54947163
Entry history
Entry creation07-Nov-2014
Last entry updated12-Mar-20
Version number9